Patients with Thyroid Dyshormonogenesis and DUOX2 Variants: Molecular and Clinical Description and Genotype-Phenotype Correlation

• Published in: International journal of molecular sciences 2024-08, Vol.25 (15), p.8473
• Main Authors: Baz-Redón, Noelia, Antolín, María, Clemente, María, Campos, Ariadna, Mogas, Eduard, Fernández-Cancio, Mónica, Zafon, Elisenda, García-Arumí, Elena, Soler, Laura, González-Llorens, Núria, Aguilar-Riera, Cristina, Camats-Tarruella, Núria, Yeste, Diego
• Format: Article
• Language: English
• Subjects: Amino acids; Biosynthesis; Congenital Hypothyroidism - genetics; Dual Oxidases - genetics; Dual Oxidases - metabolism; Enzymes; Female; Genetic Association Studies; Genotype; Genotype & phenotype; Hormones; Humans; Hypothyroidism; Infant, Newborn; Iodine; Male; Mutation; Neonatal Screening; Patients; Phenotype; Proteins; Thyroid Dysgenesis - genetics; Thyroid Dysgenesis - pathology; Thyroid gland; Thyroxine
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25158473

Thyroid dyshormonogenesis (THD) is a heterogeneous group of genetic diseases caused by the total or partial defect in the synthesis or secretion of thyroid hormones. Genetic variants in can cause partial to total iodination organification defects and clinical heterogeneity, from transient to permanent congenital hypothyroidism. The aim of this study was to undertake a molecular characterization and genotype-phenotype correlation in patients with THD and candidate variants in . A total of 31 (19.38%) patients from the Catalan Neonatal Screening Program presented with variants in that could explain their phenotype. Fifteen (48.39%) patients were compound heterozygous, 10 (32.26%) heterozygous, and 4 (12.90%) homozygous. In addition, 8 (26.67%) of these patients presented variants in other genes. A total of 35 variants were described, 10 (28.57%) of these variants have not been previously reported in literature. The most frequent variant in our cohort was c.2895_2898del/p.(Phe966SerfsTer29), classified as pathogenic according to reported functional studies. The final diagnosis of this cohort was permanent THD in 21 patients and transient THD in 10, according to reevaluation and/or need for treatment with levothyroxine. A clear genotype-phenotype correlation could not be identified; therefore, functional studies are necessary to confirm the pathogenicity of the variants.